Page 87
Novo Nordisk launches the first GLP-1 pill for obesity in the U.S., offering needle-free weight loss and shaking up a $50 billion market.
Novo Nordisk’s first GLP-1 obesity pill hits U.S. shelves, offering daily-dose convenience but facing cost and supply hurdles.
Iran’s anti-government protests stretch into a ninth night as crowds defy an internet blackout and Donald Trump hints at possible U.S. intervention.
A fresh assessment of US rocket companies shows SpaceX widening its lead while smaller rivals like Rocket Lab and Relativity Space surge, leaving legacy players scrambling.
MSI’s Stealth 16 AI+ pairs an unreleased Intel Core Ultra 300 CPU with NVIDIA’s RTX 50 GPU inside a 16-inch OLED shell that weighs under 4 lb.
The U.S. unveils redesigned quarters, dimes, and dollars to celebrate its 250th birthday, blending high-relief art with micro-engraved history.
From a 93-year-old record-breaker to Harvard labs, discover the daily tweaks—beans, micro-workouts, community—that flip your longevity genes toward a longer, healthier life.
From pickle-loving centenarians to Stanford gut-biome labs, the roadmap to 100 is cheaper—and tastier—than you think.
Trump says the U.S. will 'take charge' of Venezuela, hinting at military action to put Maduro on trial, as oil markets reel and Caracas braces.
Inside Sardinia’s Blue Zone, where centenarians thrive on beans, chores, and community—and the science that says the rest of us can copy them.